Medication is central to much of what I write about in Art of Being ILL. I’ve covered topics like knowing your meds, the opioid epidemic, overprescribing in the elderly—and I’ve got more on the way, including the top 10 most-used drugs in America and the top 5 that can quietly do harm.
There’s a lot of public attention on opioids (and rightly so), but a few other medications are flying under the radar—and their overuse is becoming just as concerning. Ozempic is one of them. It was developed for a legitimate medical need, but has since exploded into something far bigger—and more problematic.
I want to take a deeper look at this drug’s benefits, its risks, and the uncomfortable truth behind the hype. As always, I come from a place of empathy, not judgment. Obesity, diabetes, chronic illness—none of these are simple. But if we don’t slow down and question the systems we’re in, we’ll keep missing the bigger picture.
Let’s dive in.
Ozempic (semaglutide) is a GLP-1 receptor agonist. It mimics a natural hormone in the body to regulate blood sugar, slow digestion, and suppress appetite. Originally approved for type 2 diabetes, it soon became clear that it also causes significant weight loss—prompting the release of a sister drug, Wegovy, for obesity treatment.
What started as a niche diabetes medication has turned into a cultural phenomenon:
GLP-1 prescriptions have jumped 587% from 2019 to 2024.
Among young adults aged 18–39, usage increased by 588%.
Roughly 6% of Americans now take anti-obesity medications like Ozempic.
Let’s be clear—this drug can be life-changing for the right patient.
Blood Sugar Control
Clinical trials and programs like PIONEER REAL show meaningful improvements in A1C and glucose control for people with type 2 diabetes.
Weight Loss
Many users report steady monthly weight loss—5 to 10 pounds—sometimes achieving 12–20% of their body weight over a year.
Heart Health Benefits
Early data suggests GLP-1s may reduce risk of stroke and cardiovascular events.
Patient Wins
People often report increased energy, fewer cravings, and improvements in mood and self-image.
But like most things in medicine, benefits don’t come without trade-offs.
GI Issues Are Common
Nausea, vomiting, diarrhea, and bloating hit hard—sometimes so hard that people have to quit the medication. For 1 in 10, the side effects are severe.
Gastroparesis
Some users develop delayed gastric emptying, which can become chronic and debilitating. Lawsuits are already rolling in.
Pancreas & Gallbladder Risks
Studies link Ozempic to higher risks of pancreatitis, gallstones, and other GI-related complications.
Emotional & Neurological Effects
A growing number of patients report emotional dullness, depression, and a flatness in their ability to experience pleasure.
Ozempic Tongue & Taste Changes
Think metallic or bitter taste, dry mouth, and other oral symptoms—reported by about 6% of users.
Cosmetic Changes
Rapid fat loss can result in “Ozempic face,” or unwanted changes in breast, buttocks, or facial volume. For some, the change is deeply unsettling.
This is where things get murky. Ozempic is being prescribed for more than just diabetes or clinical obesity—and it’s creating new public health issues.
Unrealistic Expectations
Ozempic is not a permanent fix. When people stop taking it, weight often comes back quickly—and it’s mostly fat. This can lead to a drop in metabolism, frustration, and emotional distress.
Disordered Eating Triggers
Clinics are reporting spikes in eating disorders linked to GLP-1 use, especially among young people using the drug without proper supervision.
Access & Equity Gaps
At $1,000 a month, Ozempic is financially out of reach for many. Insurance is inconsistent. And often, wealthier, non-diabetic users get access before those who actually need it.
Black Market & Counterfeit Risk
Unregulated semaglutide is flooding the black market—sometimes with deadly consequences.
From Prevention to Prescription
We’ve shifted away from addressing the root causes of obesity—nutrition, trauma, stress, lack of access—and instead defaulted to prescribing a fix. It’s not sustainable.
Despite its popularity, Ozempic has a surprisingly high dropout rate:
65% of non-diabetic users stop within a year.
Only 22% remain on it after two years.
The reasons?
Severe side effects
Not losing as much weight as expected
Insurance and cost barriers
Emotional toll
“It worked… until I stopped. Then I gained the weight back faster than I lost it.”
“I felt sick for weeks. It just wasn’t worth it.”
“I started obsessing about food and weight in a way I hadn’t since high school.”
“I didn’t recognize my face in the mirror.”
These aren’t edge cases—they’re common.
Ozempic isn’t a villain. Used responsibly, it’s a valuable tool for managing serious chronic illness. But the current hype train is running fast, and we’re not asking the right questions:
Are patients being properly screened and monitored?
Are we treating the root causes of weight gain—like stress, food insecurity, and trauma?
Are we investing in long-term solutions like mental health care, nutrition access, and community health?
In our healthcare system, we’ve been trained to believe there’s a pill for everything. But that mindset—especially when it comes to something as complex as weight, metabolism, and mental health—can do real damage.
Ozempic is powerful. But it’s not magic.
Let’s work toward a healthcare model that prioritizes prevention, informed consent, and patient dignity over profit and short-term solutions. And let’s keep having honest conversations about the medications we use—and why.
If you’re using Ozempic, considering it, or have already stopped—your experience is valid.
And if you’re a provider, policy maker, or loved one—this is your call to pay attention. Not just to the numbers, but to the people behind them.
As always thanks for being here, it really means a lot. One small voice or share means the difference for many.
I’d love to hear your thoughts—feel free to leave a comment, like, and share with friends who might relate.
Be sure to follow artofbeingill.com for more reflections and resources.
For personal questions or collaborations, reach out at artofbeingill@gmail.com.
Visuals provided by Unsplash
Whether you read one page or all of them, you’ll find real tools, honest perspective, and a steady voice to walk beside you.
How to reclaim your voice, your calm, and your confidence-even in a hospital gown.
Your body knows. Here’s how to start listening-and what to do with what it says.
When there are no clear answers, this page helps you find steadiness in the unknown.
A look from my side of the bedside-what I’ve seen, and what every patient should know.
